Navigation Links
Nutraceutical Reports Fiscal 2013 Q3 Results
Date:7/25/2013

>

15,04614,752Other non-current assets, net

25,36727,444$ 186,940$
85,918Liabilities and Stockholders' EquityCurrent liabilities

$   20,635$
20,670Long-term liabilities

32,61734,192Stockholders' equity133,688131,056$ 186,940$
85,918NUTRACEUTICAL INTERNATIONAL CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited; dollars in thousands, except per share data)Three months ended June 30,Nine months ended June 30,2013201220132012Net sales

$
50,814$
49,607$  157,141$  150,106Cost of sales

25,93524,87879,97175,131Gross profit

24,87924,72977,17074,975Operating expensesSelling, general and administrative

17,89617,98754,32453,783Amortization of intangible assets

5564931,7011,438Impairment of intangible asset

-850-850Income from operations

6,4275,39921,14518,904Interest and other expense, net

3363881,0241,124Income before provision for income taxes

6,0915,01120,12117,780Provision for income taxes

2,2491,6597,2496,187Net income

$
3,842$
3,352$
2,872$
,593Net income per common shareBasic

$
.39$
.34$
.32$
.17Diluted

0.390.341.311.16Weighted average common shares outstandingBasic

9,765,6399,849,6749,766,4429,944,865Diluted

9,793,0459,872,0789,794,8519,960,100NUTRACEUTICAL INTERNATIONAL CORPORATIONADJUSTED EBITDA SCHEDULE(unaudited; dollars in thousands)Three months ended June 30,Nine months ended June 30,2013201220132012Net income

$ 3,842$ 3,352$ 12,872$ 11,593Provision for income taxes

2,2491,6597,2496,187Interest and other expense, net (1)

3363881,0241,124Depreciation and amortization 

2,4862,2037,3256,411Impairment of intangible asset (2)

-850-850Adjusted EBITDA

$ 8,913$ 8,452$ 28,470$ 26,165(1)

Includes amortization of deferred financing fees. (2)

A non-cash intang
'/>"/>

SOURCE Nutraceutical International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Global Nutraceuticals Industry
2. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
3. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2013
4. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
5. InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
6. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
7. Lilly Reports Second-Quarter 2013 Results
8. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
9. Danaher Reports Record Second Quarter 2013 Results
10. Pharmsynthez Reports Full Year 2012 Results in line US GAAP Financial Reporting
11. Johnson & Johnson Reports 2013 Second-Quarter Results:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Edwards Lifesciences Corporation (NYSE: EW ), the ... monitoring, today announced that Robert A. Ingram has ... is an ardent champion for innovation in the lifesciences industry, ... on Edwards, board as we pursue our focused innovation strategy," ... "Bob has provided a valuable perspective to our board, drawing ...
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 /PRNewswire/ ... that it will release its second quarter 2015 financial ... 6, 2015.   In conjunction with the release, the ... community at 5:00 p.m. Eastern Time on ... results of the quarter and other business developments. ...
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South ... for mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... South Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal ...
(Date:8/1/2015)... ... ... The condition where veins are enlarged and gnarled is known as varicose veins, ... who spend a lot of time on their feet and standing are even more ... can to create awareness and provide a cure in observance of Senior Citizen's Day ...
(Date:8/1/2015)... York, NY (PRWEB) , ... August 01, 2015 , ... ... Vine cyberespionage group , who are thought to have been behind the attack on ... the topics covered were zero day exploits, watering hole attacks and spear phishing campaigns. ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
Breaking Medicine News(10 mins):Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2
... Online Survey Examines Current Standard of Care and ... Feb. 19 A recent survey of,202 neonatologists ... caring for the specialized health needs of preterm ... United States,healthcare system does not place enough emphasis ...
... who are overweight or obese have lower concentrations of ... counterparts, according to a new study led by Duke ... results on PSA concentrations found in obese and overweight ... reconsider PSA threshold values for heavier patients, and to ...
... to recent media,reports, Roche would like to reaffirm that ... for the 2007-2008,flu season, and that physicians and patients ... strikes., Some news reports have indicated "shortages" of ... place to ensure that Tamiflu is readily,available. If a ...
... to lead Diabetes Sales, Managed Care and Government ... ... Novo Nordisk, a,healthcare company with an 85-year history of innovation ... Pamela Harris as,vice president for Diabetes Sales, Managed Care and ...
... Florida Tissue,Services, a subsidiary of LifeNet Health ... Tissue Banks (AATB)., AATB inspectors examined ... of the Association,s Standards and policies, including,record-keeping, ... suitability determinations. Tissue banks receive accreditation,from the ...
... for Two-Week Eye Health Program,in Mandalay, NEW YORK, ... Health and the Mandalay Eye and ENT Hospital, ORBIS,International, ... returns to Myanmar to conduct its ninth Flying Eye,Hospital ... from February,25 to March 7, 2008., Working together ...
Cached Medicine News:Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 2Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 3Health News:Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care 4Health News:Overweight and obese men have lower PSA values, even before they get prostate cancer 2Health News:Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide 2Health News:Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President 2Health News:Florida Tissue Services Receives National Accreditation 2Health News:ORBIS International's Flying Eye Hospital Returns to Myanmar 2
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
... the dedicated fluorometer from Berthold Technologies, ... a variety of measurement modes to ... Kinetics, scanning, dual ratio measurements plus ... a valuable instrument for any researcher ...
... stabilize the capsular bag in cases of ... specially designed for scleral fixation with suture. ... Eye Institute, recognized from his early experience ... was a need for greater stability when ...
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
Medicine Products: